Themis Bioscience Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 40

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $1.11B

Themis Bioscience General Information

Description

Themis Bioscience NV is an immunomodulation clinical-stage biopharmaceutical group that focuses on the development of products to protect against infectious diseases and for the treatment of cancer. The company has developed a vaccine platform and broad pipeline based on the advanced understanding of immune system mechanisms.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Muthgasse 11/2
  • Vienna, 1190
  • Austria
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Vertical(s)
Corporate Office
  • Muthgasse 11/2
  • Vienna, 1190
  • Austria

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Themis Bioscience Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Merger/Acquisition 19-Jun-2020 $1.11B Completed Generating Revenue
11. IPO 29-Apr-2020 Cancelled Clinical Trials - Phase 2
10. Later Stage VC (Series D) 18-Sep-2019 Completed Generating Revenue
9. Grant 04-Jun-2019 Completed Generating Revenue
8. Grant 06-Mar-2018 Completed Clinical Trials - Phase 2
7. Later Stage VC (Series C) 04-Jan-2018 Completed Clinical Trials - Phase 2
6. Later Stage VC (Series B) 29-Nov-2016 Completed Clinical Trials - Phase 2
5. Secondary Transaction - Private 01-Oct-2013 Completed Startup
4. Early Stage VC (Series A) 18-May-2011 $7.24M $8.61M Completed Startup
3. Grant 06-Jul-2010 $1.23M $1.37M Completed Startup
To view Themis Bioscience’s complete valuation and funding history, request access »

Themis Bioscience Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Themis Bioscience NV is an immunomodulation clinical-stage biopharmaceutical group that focuses on the development of pr
Biotechnology
Vienna, Austria
40 As of 2020

Warminster, PA
 

Framingham, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Themis Bioscience Competitors (33)

One of Themis Bioscience’s 33 competitors is Arbutus Biopharma, a Corporation company based in Warminster, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Arbutus Biopharma Corporation Warminster, PA
Xenetic Biosciences Corporation Framingham, MA
Agenus Formerly VC-backed Lexington, MA
Intellia Therapeutics Formerly VC-backed Cambridge, MA
Circle Pharma Venture Capital-Backed South San Francisco, CA
You’re viewing 5 of 33 competitors. Get the full list »

Themis Bioscience Patents

Themis Bioscience Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
FR-3119919-A1 Electric battery rental device and associated assembly Inactive 18-Feb-2021
WO-2022175393-A1 Electric battery rental device and associated assembly Inactive 18-Feb-2021
WO-2022038140-A1 Co-stimulatory 4-1bbl ectodomain polypeptides for immunomodulation Inactive 17-Aug-2020
EP-3673917-A1 Norovirus vaccines Inactive 28-Dec-2018
WO-2020136282-A1 Norovirus vaccines Inactive 28-Dec-2018 A61K39/295
To view Themis Bioscience’s complete patent history, request access »

Themis Bioscience Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Themis Bioscience Former Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Adjuvant Capital Impact Investing Minority
Austria Wirtschaftsservice Venture Capital Minority
Coalition for Epidemic Preparedness Innovations Impact Investing
FFG Finanzierungs- und Factorings Corporation Minority
Farallon Capital Management Hedge Fund Minority
You’re viewing 5 of 14 investors. Get the full list »

Themis Bioscience FAQs

  • When was Themis Bioscience founded?

    Themis Bioscience was founded in 2009.

  • Where is Themis Bioscience headquartered?

    Themis Bioscience is headquartered in Vienna, Austria.

  • What is the size of Themis Bioscience?

    Themis Bioscience has 40 total employees.

  • What industry is Themis Bioscience in?

    Themis Bioscience’s primary industry is Biotechnology.

  • Is Themis Bioscience a private or public company?

    Themis Bioscience is a Private company.

  • What is the current valuation of Themis Bioscience?

    The current valuation of Themis Bioscience is .

  • What is Themis Bioscience’s current revenue?

    The current revenue for Themis Bioscience is .

  • How much funding has Themis Bioscience raised over time?

    Themis Bioscience has raised $75.5M.

  • Who are Themis Bioscience’s investors?

    Adjuvant Capital, Austria Wirtschaftsservice, Coalition for Epidemic Preparedness Innovations, FFG Finanzierungs- und Factorings, and Farallon Capital Management are 5 of 14 investors who have invested in Themis Bioscience.

  • Who are Themis Bioscience’s competitors?

    Arbutus Biopharma, Xenetic Biosciences, Agenus, Intellia Therapeutics, and Circle Pharma are some of the 33 competitors of Themis Bioscience.

  • When was Themis Bioscience acquired?

    Themis Bioscience was acquired on 19-Jun-2020.

  • Who acquired Themis Bioscience?

    Themis Bioscience was acquired by Merck & Co..

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process